ClinicalTrials.gg
Enrolling by invitationNCT05215886Updated Dec 5, 2025

Cognitive Impairment, Obesity, and the Effects of Bariatric Surgery

An observational study in Obesity, Morbid and Bariatric Surgery Candidate, sponsored by University of California, Davis. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-12-05.

Sponsored by University of California, Davis · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
9,500
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 213 studies in Obesity, Morbid with a site in United States — 28 open to participants now, 36 under way, 1 of them phase 3. Obesity, Morbid · United States.

Planned enrollment
Largest of 63
9,500 · median 50
Started
2022
with 9 others
Observational
63 of 213
10 open now
Primary completion
2026-12
later than 11 of 34 live
Registered
179th of 213
by date

Among the 213 studies in Obesity, Morbid with a site in United States, this one has the largest planned enrollment of the 63 observational ones that give a count, is one of 10 that started in 2022, is one of 63 observational ones, reaches primary completion later than 11 of the 34 other live ones, and was the 179th registered.

Obesity, Morbid

941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.

Browse Obesity, Morbid studies →

Open to participants now

28 of the 213 studies in Obesity, Morbid with a site in United States are open now. Recruiting first, the newest first:

22 more — sign in →

All 28 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 213 studies in Obesity, Morbid with a site in United States, or all of them as a file.
02

Study summary

Study is designed to screen psychological cognitive baseline and retention/improvement after weight loss surgery.

Read the detailed description

Patients with morbid obesity have shown to be at increased risk for memory loss and cognitive decline. Obesity and high-fat diets have been associated with deficits in learning, memory, and executive functioning. Bariatric surgery results in significant weight loss for patients and helps resolve obesity-related comorbidities such as diabetes and high blood pressure. Interestingly, bariatric surgery has shown promise in improving some aspects of cognitive function and improved memory. (3-1) Obesity affects brain structure, more specifically the grey and white matter, likely in part by reducing oxygen flow to the various regions in the brain. Studies have shown a correlation between BMI and cerebral blood flow velocity (CBFV), where higher BMI is associated with lower CBFV. Although it is not clear how exactly obesity plays a role in the brain's structural and functional changes, observations revealed compromised grey and white matter integrity, its fiber connectivity or cortical atrophy and metabolic alterations. (2)

Few studies exist on the impact of bariatric surgery on cognition. Some studies have shown that patients with obesity who underwent bariatric surgery had memory and cognitive improvement compared to those who had not undergone surgery. (4) Thus, the investigators hope to add to our understanding of how bariatric surgery can improve cognitive decline and to potentially offer surgery to more patients with baseline cognitive impairment and to improve cognitive function overall for patients with obesity. More longitudinal studies need to be done to connect bariatric surgery effects with cognitive decline, specifically memory.

03

Conditions studied

  • Obesity, Morbid
  • Bariatric Surgery Candidate

Keywords

  • Obesity
  • Bariatric Surgery
  • Cognitive Screening
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects seeking weight loss surgery or with a history of weight loss surgery at University of California Davis Medical Center 18 years of age or older

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease or dementia and bariatric surgery • Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatric surgery history

Exclusion criteria

Exclusion Criteria:

  • Patients without a history of memory impairment/loss, bariatric surgery, or obesity

    • Patients outside of University of California Davis Health System
    • Patients unable to provide consent
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
9,500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Surgery

    Patients scheduled for or have already completed Weight Loss Surgery at UC Davis Medical Center

    Behavioral: Surgery

Interventions

  • BehavioralSurgery

    Study subjects scheduled for or have already completed weight loss surgery and have already completed psychological screening as part of their pre-surgery work up

06

What researchers measure

Primary outcomes

  1. California Verbal Learning Test-3rd Edition (CVLT-3)

    Measures episodic verbal learning including Verbal Learning, immediate memory, and delayed memory

    Time frame: Pre-operatively

  2. California Verbal Learning Test-3rd Edition (CVLT-3)

    Measures episodic verbal learning including Verbal Learning, immediate memory, and delayed memory

    Time frame: 12 Months after index screening/date of surgery

Secondary outcomes

  1. Brief Visuospatial Memory Test

    Measures visuospatial learning and memory, including visual learning, immediate memory, and delayed memory.

    Time frame: Pre-operatively and 12 months after index screening/date of surgery

  2. Brief Visuospatial Memory Test

    Measures visuospatial learning and memory, including visual learning, immediate memory, and delayed memory.

    Time frame: Pre-operatively

  3. Trial Making Test, A & B

    Measures visual spatial attention, motor speed and cognitive flexibility

    Time frame: 12 months after index screening/date of surgery

  4. WAIS-IV Digit Span Forward & Backward

    Measures auditory Attention (Forward), and Auditory attention and working memory (Backward)

    Time frame: Pre-Operatively

  5. WAIS-IV Digit Span Forward & Backward

    Measures auditory Attention (Forward), and Auditory attention and working memory (Backward)

    Time frame: 12 months after Index screening/date of surgery

  6. Verbal Fluency, Phonemic & Semantic

    Measures verbal fluency by a word generation task based on letter \& category (executive functioning)

    Time frame: Pre-operatively

  7. Verbal Fluency, Phonemic & Semantic

    Measures verbal fluency by a word generation task based on letter \& category (executive functioning)

    Time frame: 12 months after index screening/date of surgery

  8. Stroop Color and Word Test; Word, Color & Word-Color

    Measures reading speed (word), naming speed (processing) and selective attention and inhibition (attention/executive functioning)

    Time frame: Pre-Operatively

  9. Stroop Color and Word Test; Word, Color & Word-Color

    Measures reading speed (word), naming speed (processing) and selective attention and inhibition (attention/executive functioning)

    Time frame: 12 months after index screening/date of surgery

07

Study locations

1 site
08

References and documents

Publications

  • Alosco ML, Spitznagel MB, Strain G, Devlin M, Cohen R, Paul R, Crosby RD, Mitchell JE, Gunstad J. Improved memory function two years after bariatric surgery. Obesity (Silver Spring). 2014 Jan;22(1):32-8. doi: 10.1002/oby.20494. Epub 2013 Oct 15. PubMed 23625587 ↗
  • Nota MHC, Vreeken D, Wiesmann M, Aarts EO, Hazebroek EJ, Kiliaan AJ. Obesity affects brain structure and function- rescue by bariatric surgery? Neurosci Biobehav Rev. 2020 Jan;108:646-657. doi: 10.1016/j.neubiorev.2019.11.025. Epub 2019 Nov 30. PubMed 31794778 ↗
  • Miller AA, Spencer SJ. Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav Immun. 2014 Nov;42:10-21. doi: 10.1016/j.bbi.2014.04.001. Epub 2014 Apr 12. PubMed 24727365 ↗
  • Stanek KM, Gunstad J. Can bariatric surgery reduce risk of Alzheimer's disease? Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:135-9. doi: 10.1016/j.pnpbp.2012.06.021. Epub 2012 Jul 4. PubMed 22771689 ↗

Individual participant data

Plan to share: Undecided — No plan in place (yet) for data sharing

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2022 (actual). Primary completion is estimated for Dec 2026, 59 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 18, 2022
First posted
Jan 31, 2022
StartActual
Jan 1, 2022
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2028
Last update
Dec 5, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05215886
Responsible party
Sponsor
First posted
Jan 31, 2022
Start date
Jan 1, 2022
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Dec 5, 2025

Study contacts

Victoria Lyo, MD
principal investigator · University of California, Davis

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion